Burn Validation Study
BVS
Performance Evaluation of the DeepView AI-Burn For Assessment of Thermal Burn Healing Potential
1 other identifier
observational
274
1 country
21
Brief Summary
The purpose of this study is to validate the algorithm for burn healing assessment by the Spectral MD DeepView device which would provide burn healing potential assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
21 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2023
CompletedFirst Posted
Study publicly available on registry
November 14, 2023
CompletedStudy Start
First participant enrolled
December 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedApril 25, 2025
April 1, 2025
1.2 years
November 8, 2023
April 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Primary BC Endpoint
Demonstrate the DeepView AI-Burns' sensitivity is superior to BC HCPs' bedside examination while maintaining non-inferior specificity to burn HCPs.
3 weeks
Study Arms (2)
Emergency Department Burn Subjects
Subjects with Thermal Burn Injury enrolled through the emergency department
Burn Center Burn Subjects
Subjects with Thermal Burn Injury enrolled through the burn center
Interventions
DV-SSP assistive imaging to collect observational data
Eligibility Criteria
Subjects enrolled in this study will be recruited at the designated Study Site within 72 hours of suffering a thermal burn injury. Adult and pediatric Subjects with burns from one or more of the defined burn severities will be enrolled. All Subjects must meet the specified inclusion criteria.
You may qualify if:
- Willing and able to give informed consent or have a Legally Authorized Representative (LAR) able to do so; Life expectancy \> 6 months; Thermal burn mechanism (flame, scald, or contact); The Study Burn(s) occurred less than 72 hours prior to the time of first imaging; and Minimum burn wound size for adult or pediatric patients is 0.5% TBSA per region For adult Subjects: Have 2 - 4 regions of their clinical burn(s) that meet the criteria for a Study Burn.
- For pediatric Subjects: Have 1 - 4 regions of their clinical burn(s) that meet the criteria for a Study Burn
You may not qualify if:
- Burn pattern distribution isolated to head, face, neck, hands, feet, genitalia, and/or joints; Subject has burns involving \> 50% total body surface area (TBSA); Sepsis at the time of enrollment; Immunosuppression/radiation/chemotherapy \< 3 months prior to enrollment; Concurrent use of investigational products with a known effect on the burn sites; and/or Any condition that in the opinion of the Investigator may prevent compliance with the study requirements or compromise subject safety.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SpectralMDlead
Study Sites (21)
Valleywise Health
Phoenix, Arizona, 85008, United States
Shriners Children's Northern California
Sacramento, California, 95817, United States
University of California Davis Health
Sacramento, California, 95817, United States
University of California San Diego
San Diego, California, 92093, United States
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Tampa General Hospital
Tampa, Florida, 33606, United States
University of Iowa
Iowa City, Iowa, 52242, United States
University of Kansas Medical Center
Kansas City, Kansas, 66103, United States
University of Louisville
Louisville, Kentucky, 40202, United States
University Medical Center
New Orleans, Louisiana, 70112, United States
University of Rochester
Rochester, New York, 14642, United States
SUNY Stony Brook Medical Center
Stony Brook, New York, 11794, United States
University of North Carolina Chapel Hill
Chapel Hill, North Carolina, 27514, United States
Akron Children's Hospital
Akron, Ohio, 44308, United States
Ohio State University
Columbus, Ohio, 43210, United States
St. Christopher's Children Hospital
Philadelphia, Pennsylvania, 19134, United States
MUSC Shawn Jenkins Children's Hospital
Charelston, South Carolina, 29425, United States
Texas Tech University
Lubbock, Texas, 79409, United States
University of Utah Health
Salt Lake City, Utah, 84132, United States
Virginia Commonwealth University
Richmond, Virginia, 23284, United States
University of Washington Harborview
Seattle, Washington, 98104, United States
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2023
First Posted
November 14, 2023
Study Start
December 19, 2023
Primary Completion
March 17, 2025
Study Completion
April 1, 2025
Last Updated
April 25, 2025
Record last verified: 2025-04